SIRPA and colorectal cancer: KWAR23 induced phagocytosis of the DLD‐1 human colorectal cancer cell line across SIRPα variants with equivalent potencies, suggesting that there is no inherent difference in phagocytic capacity of macrophages from patients with different SIRPα variants.